$TGTX - Congrats to those who own this, very nice up day! Up 30%!. We are still watching this and thinking it shall go higher in time, drug trial data was outstanding. TG Therapeutics analyst commentary at B. RileyFBR TG Therapeutics price target raised to $17 from $12 at B. Riley FBR. B. Riley FBR analyst Mayank Mamtani raised his price target for TG Therapeutics to $17 from $12 citing the company's "solid" Phase I/II triplet data. The data paint a "bright future," says the analyst, who reiterates a Buy rating on TG Therapeutics. $TGTX, TG Therapeutics, Inc. / H1 Disclosure: I may trade in the ticker symbols mentioned, both long or short. My articles represent my personal opinion and analysis and should not be taken as investment advice. Readers should do their own research before making decisions to buy or sell securities. Trading and investing include risks, including loss of principal. If you liked this article, please click the LIKE (thumbs up) button. Feel free to leave any comments, question, or opinions. (Sign-up if you haven't already done so). Follow us/bookmark us and check back occasionally for additional articles or comments on our page... Wild Tiger Trading - start/main page